These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 678451)

  • 1. Corticosteroid effect on epidermal cell size.
    Delforno C; Holt PJ; Marks R
    Br J Dermatol; 1978 Jun; 98(6):619-23. PubMed ID: 678451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acid mucopolysaccharide synthesis by hydrocortisone, hydrocortisone 17-butyrate and betamethasone 17-valerate.
    Saarni H; Hopsu-Havu VK
    Br J Dermatol; 1977 Nov; 97(5):505-7. PubMed ID: 145236
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid atrophy--a histological appraisal.
    Jones EW
    Dermatologica; 1976; 152 Suppl 1():107-15. PubMed ID: 133833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
    Priestley GC
    Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.
    Kerscher MJ; Korting HC
    Acta Derm Venereol; 1992; 72(3):214-6. PubMed ID: 1357864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic assay of betamethasone 17-valerate and its degradation products.
    Li Wan Po A; Irwin WJ; Yip YW
    J Chromatogr; 1979 Sep; 176(3):399-405. PubMed ID: 546923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect on epidermal DNA synthesis of a combination of topical steroid with either dithranol or tar as used for psoriasis.
    Clement M; Hehir M; Phillips H; du Vivier A
    Br J Dermatol; 1983 Sep; 109(3):327-35. PubMed ID: 6615719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of five anti-inflammatory steroids on collagen and glycoaminoglycan synthessis in vitro.
    Saarni H; Jalkanen M; Hopsu-Havu VK
    Br J Dermatol; 1980 Aug; 103(2):167-73. PubMed ID: 7426413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application.
    Bromley PA; Müller FO; Malan J; Torres J; Vanderbeke O
    S Afr Med J; 1978 Aug; 54(6):239-41. PubMed ID: 362568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-induced atrophy in an animal and human model.
    Kirby JD; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():111-9. PubMed ID: 1268071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties and therapeutic uses of some corticosteroids with enhanced topical potency.
    Harris DM
    J Steroid Biochem; 1975 May; 6(5):711-6. PubMed ID: 1186253
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of betamethasone 17 valerate on the cyclic AMP system of the pig skin epidermis.
    Ishizawa H; Iizuka H; Kajita S; Ohkawara A
    J Dermatol; 1983 Aug; 10(4):321-5. PubMed ID: 6321577
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
    Cossmann M; Welzel J
    Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrocortisone butyrate on collagen synthesis.
    Saarni H; Hopsu-Havu VK
    Br J Dermatol; 1976 Nov; 95(5):566-7. PubMed ID: 990175
    [No Abstract]   [Full Text] [Related]  

  • 20. Contact allergic reaction to valerate esters of betamethasone and hydrocortisone.
    Koch EM
    Contact Dermatitis; 1985 Jan; 12(1):58. PubMed ID: 3979047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.